Detection of circulating and endothelial cell polymers of Z and wild type α1-antitrypsin by a monoclonal antibody

被引:63
作者
Janciauskiene, S
Dominaitiene, R
Sternby, NH
Piitulainen, E
Eriksson, S
机构
[1] Malmo Univ Hosp, Dept Resp Med, S-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Dept Pathol, S-20502 Malmo, Sweden
[3] Malmo Univ Hosp, Dept Internal Med, S-20502 Malmo, Sweden
关键词
D O I
10.1074/jbc.M203832200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Globular inclusions of abnormal alpha1-antitrypsin (AAT) in the endoplasmic reticulum of hepatocytes are a characteristic feature of AAT deficiency of the PiZZ phenotype. Monoclonal antibodies, which contain constant specificity and affinity, are often used for the identification of Z-mutation carriers. A mouse monoclonal antibody (ATZ11) raised against PiZZ hepatocytic AAT was successfully used in enzyme-linked immunosorbent assays (ELISA) and in identification of Z-related AAT globular inclusions by immunohistochemical techniques. Using electrophoresis, Western blotting, and ELISA procedures, we have shown in the present study that this monoclonal antibody specifically detects a conformation-dependent neoepitope on both polymerized and elastase-complexed molecular forms of AAT. The antibody has no apparent affinity for native, latent, or cleaved forms of AAT. The antibody ATZ11 illustrates the structural resemblance between the polymerized form of AAT and its complex with elastase and provides evidence that Z-homozygotes beyond the native form may have at least one more circulating molecular form of AAT, i.e. its polymerized form. In addition, staining of endothelial cells with ATZ11 antibody in both M- and Z-AAT individuals shows that AAT attached to endothelial cells is in a polymerized form. The antibody can be a powerful tool for the study of the molecular profile of AAT, not only in Z-deficiency cases but also in other (patho)physiological conditions.
引用
收藏
页码:26540 / 26546
页数:7
相关论文
共 61 条
[31]   EFFECT OF THE Z-MUTATION ON THE PHYSICAL AND INHIBITORY PROPERTIES OF ALPHA-1-ANTITRYPSIN [J].
LOMAS, DA ;
EVANS, DL ;
STONE, SR ;
CHANG, WSW ;
CARRELL, RW .
BIOCHEMISTRY, 1993, 32 (02) :500-508
[32]   PREPARATION AND CHARACTERIZATION OF LATENT ALPHA(1)-ANTITRYPSIN [J].
LOMAS, DA ;
ELLIOTT, PR ;
CHANG, WSW ;
WARDELL, MR ;
CARRELL, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5282-5288
[33]  
Lomas DA, 2000, RESP MED, V94, pS3, DOI 10.1053/rmed.2000.0850
[34]   Expression of α-1 proteinase inhibitor in human islet microvascular endothelial cells [J].
Lou, JN ;
Triponez, F ;
Oberholzer, J ;
Wang, HY ;
Yu, DM ;
Buhler, L ;
Cretin, N ;
Mentha, G ;
Wollheim, CB ;
Morel, P .
DIABETES, 1999, 48 (09) :1773-1778
[35]   SERP1, A SERINE PROTEINASE-INHIBITOR ENCODED BY MYXOMA VIRUS, IS A SECRETED GLYCOPROTEIN THAT INTERFERES WITH INFLAMMATION [J].
MACEN, JL ;
UPTON, C ;
NATION, N ;
MCFADDEN, G .
VIROLOGY, 1993, 195 (02) :348-363
[36]   Alpha1-antitrypsin deficiency, cirrhosis and emphysema [J].
Mahadeva, R ;
Lomas, DA .
THORAX, 1998, 53 (06) :501-505
[37]   CELL-SPECIFIC EXPRESSION OF ALPHA(1)-ANTITRYPSIN IN HUMAN INTESTINAL EPITHELIUM [J].
MOLMENTI, EP ;
PERLMUTTER, DH ;
RUBIN, DC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :2022-2034
[38]   Effects of noninhibitory α-1-antitrypsin on primary human monocyte activation in vitro [J].
Moraga, F ;
Lindgren, S ;
Janciauskiene, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 386 (02) :221-226
[39]   TYPE-1 INHIBITOR OF PLASMINOGEN ACTIVATORS - DISTINCTION BETWEEN LATENT, ACTIVATED AND REACTIVE CENTER-CLEAVED FORMS WITH THERMAL-STABILITY AND MONOCLONAL-ANTIBODIES [J].
MUNCH, M ;
HEEGAARD, C ;
JENSEN, PH ;
ANDREASEN, PA .
FEBS LETTERS, 1991, 295 (1-3) :102-106
[40]  
Nakatani K, 2001, J LEUKOCYTE BIOL, V69, P241